Guang Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Guang Yang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Chenghu Wang
Neonatal Internal Medicine, Children's Hospital of Shanxi, PR China
1 shared publication - Guang Yang
Department of Pediatrics, Shanxi Medical University, Taiyuan, China; Neonatal Internal Medicine, Children's Hospital of Shanxi, Taiyuan, China
1 shared publication - Mingyan Hei
Neonatal Center, Beijing Children's Hospital Capital Medical University Beijing China
1 shared publication Xinhua Zhang
Neonatal Internal Medicine, Children's Hospital of Shanxi, PR China
1 shared publication- Yuan Zhao
Department of Pediatrics, The Sixth Medical Center of PLA General Hospital, Beijing, People’s Republic of China
1 shared publication - Yuan Zhao
School of Nursing, Dali University, China
1 shared publication
Latest Publications
- Open Access
- 1 February 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (9) , e19216
Effects of less invasive surfactant administration (LISA) via a gastric tube on the treatment of respiratory distress syndrome in premature infants aged 32 to 36 weeks
To explore the clinical effects of less invasive surfactant administration (LISA) via a gastric tube on the treatment of respiratory distress syndrome (RDS) in premature infants aged 32 to 36 weeks. A total of 97 premature infants with RDS admitted to the Children's Hospital of Shanxi from February 2017 to January 2018 were randomly divided into LISA (47 cases) and (intubation-surfactant-extubation,) INSURE groups (50 cases). In the LISA group, 6F gastric tubes were inserted into the trachea through direct laryngoscopy under nasal continuous positive airway pressure (NCPAP), and pulmonary surfactant (PS) was injected. In the INSURE group, PS was injected via tracheal intubation and NCPAP was performed after extubation. The incidence of technical-related adverse events and various complications in the two groups were observed. PS was successfully injected through gastric tube in the LISA group. There were no significant differences in reflux, asphyxia, bradycardia (2, changes in PaO2 and PaCO2 at 1 hour post-treatment between the groups. During the course of administration, blood pressure and SpO2 in the LISA group were more stable, and significant differences between the 2 groups were observed. However, no significant differences in the complications and outcomes between the 2 groups occurred. The LISA technique can be used to treat premature infants with RDS aged 32 to 36 weeks with stronger spontaneous breathing ability. Further clinical studies are required to determine the optimal strategy of LISA administration and the most profitable patient population.
- 1 February 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (9) , e19216
Open AccessEffects of less invasive surfactant administration (LISA) via a gastric tube on the treatment of respiratory distress syndrome in premature infants aged 32 to 36 weeks
To explore the clinical effects of less invasive surfactant administration (LISA) via a gastric tube on the treatment of respiratory distress syndrome (RDS) in premature infants aged 32 to 36 weeks. A total of 97 premature infants with RDS admitted to the Children's Hospital of Shanxi from February 2017 to January 2018 were randomly divided into LISA (47 cases) and (intubation-surfactant-extubation,) INSURE groups (50 cases). In the LISA group, 6F gastric tubes were inserted into the trachea through direct laryngoscopy under nasal continuous positive airway pressure (NCPAP), and pulmonary surfactant (PS) was injected. In the INSURE group, PS was injected via tracheal intubation and NCPAP was performed after extubation. The incidence of technical-related adverse events and various complications in the two groups were observed. PS was successfully injected through gastric tube in the LISA group. There were no significant differences in reflux, asphyxia, bradycardia (2, changes in PaO2 and PaCO2 at 1 hour post-treatment between the groups. During the course of administration, blood pressure and SpO2 in the LISA group were more stable, and significant differences between the 2 groups were observed. However, no significant differences in the complications and outcomes between the 2 groups occurred. The LISA technique can be used to treat premature infants with RDS aged 32 to 36 weeks with stronger spontaneous breathing ability. Further clinical studies are required to determine the optimal strategy of LISA administration and the most profitable patient population.
- Open Access
- 1 January 2020
- Published by XMLink in Yonsei Medical Journal
- Vol. 61 (8) , 660-669
Overexpression of miR-146b-5p Ameliorates Neonatal Hypoxic Ischemic Encephalopathy by Inhibiting IRAK1/TRAF6/TAK1/NF-αB Signaling
Yang G, et al. Yonsei Med J. 2020 Aug;61(8):660-669. https://doi.org/10.3349/ymj.2020.61.8.660
- 1 January 2020
- Published by XMLink in Yonsei Medical Journal
- Vol. 61 (8) , 660-669
Open AccessOverexpression of miR-146b-5p Ameliorates Neonatal Hypoxic Ischemic Encephalopathy by Inhibiting IRAK1/TRAF6/TAK1/NF-αB Signaling
Yang G, et al. Yonsei Med J. 2020 Aug;61(8):660-669. https://doi.org/10.3349/ymj.2020.61.8.660